9 analysts have expressed a variety of opinions on Phreesia (NYSE:PHR) over the past quarter, offering a diverse set of opinions from bullish to bearish. The following table summarizes their ...

Earnings Estimate Revisions for Phreesia For the fiscal year ending January 2025, this developer of health care software is expected to earn -$1.10 per share, which is a change of 56.2% from the ...

Phreesia (PHR) reported $106.8 million in revenue for the quarter ended October 2024, representing a year-over-year increase of 16.6%. EPS of -$0.25 for the same period compares to -$0.58 a year ago.

Phreesia (PHR) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #2 (Buy). An upward trend in earnings estimates -- one of the most powerful forces impacting ...